K202928

Substantially Equivalent

DV. Target

Applicant: Deepvoxel, Inc.
Product code: QKB
Advisory panel: Radiology
Date received: 2020-09-29
Decision date: 2021-04-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.